Entity
  • Porsolt

    Created in 1999
  • Social networks

    2,365
  • Activities

  • Technologies

  • Entity types

  • Location

    53940 Le Genest-Saint-Isle, France

    Le Genest-Saint-Isle

    France

  • Employees

    Scale: 51-200

    Estimated: 85

  • SIREN

    425113321
  • Engaged corporates

    3
    1 3
  • Added in Motherbase

    3 years, 2 months ago
Description
  • Value proposition

    Scientist-to-Scientist

    Porsolt is a long-established preclinical CRO, having started operations in 1984 under the name ITEM-Labo. Porsolt has obtained an international reputation for expertise in physiopathological models, customized procedures and tailored solutions for discovering treatments of psychiatric and neurological disorders, acute and chronic pain, inflammation, cardiac and vascular diseases, and metabolic and eating disorders. Porsolt also offers services for safety evaluation of drug candidates from screening to pre-Phase 1 regulatory studies (ICH S7), in full compliance with GLP. Porsolt’s safety program includes full assessment of arrhythmogenic risk and abuse/dependence liability.
    Porsolt is headquartered in France with research facilities in Laval.
    For additional information about the organization, please visit www.porsolt.com or email us at contact@porsolt.com

    Efficacy & Safety Pharmacology, Cardiovascular System, Central Nervous System, Inflammation, Metabolism & Eating disorders, Gastrointestinal system, Abuse and Dependence Liability, PK & PD, Oncology, Renal & Urogenital systems, Pain, Dermatology, Predictive toxicity, Liver & Hepatic System, Respiratory System, Thrombosis & Blood, Early-drug discovery, Screening, Efficacy, and Safety

  • Original language

    Scientist-to-Scientist

    Porsolt is a long-established preclinical CRO, having started operations in 1984 under the name ITEM-Labo. Porsolt has obtained an international reputation for expertise in physiopathological models, customized procedures and tailored solutions for discovering treatments of psychiatric and neurological disorders, acute and chronic pain, inflammation, cardiac and vascular diseases, and metabolic and eating disorders. Porsolt also offers services for safety evaluation of drug candidates from screening to pre-Phase 1 regulatory studies (ICH S7), in full compliance with GLP. Porsolt’s safety program includes full assessment of arrhythmogenic risk and abuse/dependence liability.
    Porsolt is headquartered in France with research facilities in Laval.
    For additional information about the organization, please visit www.porsolt.com or email us at contact@porsolt.com

  • Home - PORSOLT

    Porsolt is an internationally recognized Global CRO (Contract Research Organization). We assist our clients at all stages of the preclinical drug development process. We are GLP compliant and we are an AAALAC accredited facility.

  • https://www.porsolt.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Teva Pharmaceuticals
Teva Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Teva Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Other

12 Dec 2023


Business France
Business France
National and local authorities, Government Administration
Business France
National and local authorities, Government Administration
Other

30 Apr 2023


Atlanpole Biotherapies
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

2 Mar 2023


Similar entities
Loading...
Loading...
Social network dynamics